NEWSnet Anchorage
    • Homepage
Innovation Beverage Group Announces Receipt of Nasdaq Notice of Annual Shareholder Meeting Noncompliance

Author: Spur Therapeutics

Posted Date:

January 25, 2026
  • Spur Therapeutics Announces Platform and Poster Presentations Highlighting New Clinical Data for FLT201 in Gaucher Disease at Upcoming WORLDSymposiumâ„¢

    Spur Therapeutics
    January 25, 2026